Portland, OR, Sept. 02, 2020 (GLOBE NEWSWIRE) — Cell therapy is considered an integral part of immunotherapy and has shown excellent therapeutic ability in clinical indications. Studies related to the use of cells for therapeutic ability has gained tremendous popularity in healthcare as well as scientific community. The Cell Therapy Market has gained immense popularity globally due to the advent of techniques like stem cell therapy, CAR-T cell therapy, and cord blood cell therapy. Each of the therapies has gained traction owing to their extensive application in cancer and cardiovascular diseases.
Download Sample Report with Detailed COVID-19 Impact Analysis at: https://www.alliedmarketresearch.com/request-for-customization/5330?reqfor=covid
Market Dynamics- Drivers
Increasing research and development activities are expected to drive growth of the stem cell therapy market
Increasing research and development activities are expected to drive growth of the global stem cell therapy market during the forecast period. For instance, in January 2010, the Augusta University (U.S.) initiated Phase I clinical trial to evaluate the safety and effectiveness of a single, autologous cord blood stem infusion for treatment of cerebral palsy in children. The study is estimated to complete in July 2019. Cerebral palsy is a severe, lifelong disability disease that affects children, and has various signs and symptoms such as poor coordination, stiff muscles, and tremors.
Increasing product launches by market players is expected to propel the global stem cell therapy market over the